Genetics and Pharmacogenetics of Obsessive-Compulsive Disorder
Top papers:
1. Salari, M., Etemadifar, M., Neshat ghalibaf M., Azizi F., Davoodi M., Asadi, S., 2023, Neurodegeneration, Ataxia, Dystonia, and Gaze Palsy (NADGP) Syndrome with Nocturnal Paroxysmal Head Tremor. Movement disorders clinical practice, 10(5), 835-838.
2. Ghavidel N, Khodagholi F, Ahmadiani A, Khosrowabadi R, Asadi S, Shams J, 2020, Inflammation but Not Programmed Cell Death Is Activated in Methamphetamine-Dependent Patients: Relevance to The Brain Function. International Journal of Psychophysiology, 157, 42-50.
3. Ghavidel N, Khodagholi F, Ahmadiani A, Khosrowabadi R, Asadi S, Shams J, 2020, Frontocingulate Dys-function is Associated with Depression and Decreased Serum PON1 in Methamphetamine Dependant Patients. Neuropsychiatric Disease and Treatment, 16: 489-499.
4. Hasanpour H, Ghavamizadeh Meibodi R, Asadi S, Navi K, 2019, Fluvoxamine treatment response predic-tion in obsessive-compulsive disorder: association rule mining approach. Neuropsychiatric disease and treatment, 15: 895-904.
5. Alizadeh N, Nosrat N, Jahani Z, Ahmadiani A, Shams J, Asadi S, 2019, Association of HTR1A gene poly-morphisms with Obsessive-Compulsive Disorder: The influence of sex and clinical characteristics, Inter-national Journal of Neuroscience, 129: 264-272.